Skip to main contentAI and Advanced
/
AJOONI · NSEBSE SENSEX74,294.96-0.03%BSE |
NIFTY 5023,346.4+0.33%NSE |
NIFTY BANK56,358.7+0.54%NSE |
NIFTY IT28,854.55-1.03%NSE |
NIFTY AUTO27,129-0.11%NSE |
NIFTY FMCG45,466.8-0.23%NSE |
NIFTY PHARMA26,710.1+0.49%NSE |
NIFTY 50022,840.55+0.82%NSE |
AJ
NSE · Equity shares · Food Processing-0.06 · -1.20%
Ajooni Biotech AJOONI
NSE:INR 4.18
BSE:Not available
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for AJOONI
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 4.24
Day rangeINR 3.2 — INR 3.34
52-week rangeINR 3.08 — INR 5.94
Volume2.98 L
Market cap72.69
P/E13.85
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)182.38
Net Income (INR Cr)4.32
Rev Growth (5 Year %)29.01
EPS Growth (5 Year %)34.05
P/E Ratio13.85
Book Value5.27
EPS0.25
Price/BV0.79Computed
Research path: Interpret Ajooni Biotech's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
AJOONIAjooni Biotech1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 120.37 | 95.05 | 47.52 |
| Other Liabilities Total | 0.29 | 0.21 | 0.12 |
| Accrued Expenses | 0.02 | 0.01 | 0.01 |
| Long Term Debt | 1.02 | 1.94 | 1.68 |
| Common Stock Total | 34.45 | 34.45 | 17.52 |
| Other Current Assets Total | 1.92 | 1.39 | 0.06 |
| Total Assets | 120.37 | 95.05 | 47.52 |
| Current Portof LT Debt/Capital Leases | 16.74 | 0 | 0.49 |
| Cash | 0.42 | 6.83 | 0.43 |
| Total Equity | 91.19 | 88.08 | 42.71 |
| Long Term Investments | 17.45 | 18.56 | 2.14 |
| Retained Earnings(Accumulated Deficit) | 56.74 | 53.63 | 25.19 |
| Total Common Shares Outstanding | 17.22 | 17.22 | 9.94 |
| Tangible Book Valueper Share Common Eq | 5.27 | 5.09 | 4.3 |
| Total Liabilities | 29.17 | 6.97 | 4.81 |
| Total Debt | 17.76 | 1.94 | 2.17 |
| Short Term Investments | 0.7 | 0.27 | 0 |
| Cashand Short Term Investments | 1.12 | 7.1 | 0.43 |
| Total Receivables Net | 31.98 | 29.52 | 16.47 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 |
| Accounts Receivable-Trade Net | 17.83 | 16.22 | 12.96 |
| Property/Plant/Equipment Total-Net | 25.86 | 11.23 | 11.24 |
| Total Current Liabilities | 27.86 | 4.82 | 3.01 |
| Total Inventory | 39.46 | 23.99 | 15.37 |
| Accounts Payable | 8.91 | 3.5 | 1.58 |
| Other Currentliabilities Total | 2.19 | 1.32 | 0.93 |
| Total Long Term Debt | 1.02 | 1.94 | 1.68 |
| Intangibles Net | 0.36 | 0.48 | Not available |
| Other Long Term Assets Total | 1.73 | 2.4 | 1.5 |
| Note Receivable-Long Term | 0.49 | 0.38 | 0.31 |
| Total Current Assets | 74.48 | 62 | 32.33 |
Fundamentals
Valuation and ratios
Valuation
PEG Ratio0.5
Price to Sale Ratio0.40
Growth
Debt 5Yr CAGR %21.23
Margins
Operating Margin 12m2.22
Operating Margin 5y Avg2.23
Net Profit Margin 12m2.36
Net Profit Margin 5y2.29
Yield
Dividend Yield %0
Risk and consensus
Source-qualified signals
Risk metrics
Risk metrics unavailable.
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Nestle India | INR 1,483 | 2.87 L | 80.4 | — |
| Britannia Industries | INR 5,498.7 | 1.32 L | 51.47 | — |
| Tata Consumer Products | INR 1,085.7 | 1.07 L | 67.4 | — |
| Godrej Industries | INR 1,357.45 | 45,725.84 | 34.92 | — |
| Patanjali Foods | INR 335.5 | 36,506.05 | 18.91 | — |
Shareholding
Ownership
- Promoter
- 26.89%
- FII
- 0.18%
- Other
- 73.11%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Ajooni Biotech website updated per SEBI LODR Regulation 46 - scanx.tradeMarket news · 15 Jul 2026, 3:11 am
Ajooni Biotech website updated per SEBI LODR Regulation 46 scanx.trade
Ajooni Biotech Ltd is Rated Sell - MarketsMojoMarket news · 10 Jul 2026, 10:15 am
Ajooni Biotech Ltd is Rated Sell MarketsMojo
Ajooni Biotech to hold 16th AGM on July 29, 2026 - scanx.tradeMarket news · 1 Jul 2026, 12:30 pm
Ajooni Biotech to hold 16th AGM on July 29, 2026 scanx.trade
Enterprise value to EBITDA forward of Ajooni Biotech Limited – NSE:AJOONI - TradingViewMarket news · 27 Jun 2026, 12:32 am
Enterprise value to EBITDA forward of Ajooni Biotech Limited – NSE:AJOONI TradingView
Ajooni Biotech closes trading window from July 01 for Q1FY26 results - scanx.tradeMarket news · 23 Jun 2026, 3:24 am
Ajooni Biotech closes trading window from July 01 for Q1FY26 results scanx.trade
Ajooni Biotech Q4 Results 2026 - Find Ajooni Biotech Q4 Earnings Result | AJOONI Q4 results - MintMarket news · 19 Jun 2026, 12:30 pm
Ajooni Biotech Q4 Results 2026 - Find Ajooni Biotech Q4 Earnings Result | AJOONI Q4 results Mint
Corporate actions
Events
- board MeetingsTo consider other business matters.
- board MeetingsAudited Results
- board MeetingsTo consider other business matters
- board MeetingsQuarterly Results
- annual General MeetingAGM
- board MeetingsTo consider other business matters
- board MeetingsTo consider other business matters
- board MeetingsQuarterly Results
Rusaka Markets Community
Discussion and sentiment for Ajooni Biotech
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Ajooni Biotech Limited is an animal health care solutions company. The Company is specialized in compounded animal feed and feed supplements. Its portfolio offers a wide range of quality cattle feed; cattle feed chips, camel feed, cotton oil cake, mustard oil cake and a wide range of feed supplements to cover the entire life cycle of an animal. The Company uses technologies for all its operations, such as Enterprise Resource Planning (ERP) software, programmable logic controller (PLC) system to control production process. It offers products for oral calclum, bloating, calclum gel, mastitis powder, mineral mixture, batisa powder, liver tonic, reproduction powder, utrine tonic, milk gainer, multi vitamin, growth promoter, foot and mouth disease (FMD) powder, cough syrup, egg growth promoter, and heat stock powder. Its feed supplements include CALTUS, 4U, LIVTUS, RUMITUS, Mustmin, AUTOVITA and others. Its cattle feed products include Gold Magic plus, Silver Magic, 3 Star, among others.
Company facts
- Industry
- Food Processing
- Sector
- Food Processing
- NSE Code
- AJOONI
Questions
Stock FAQ
What is the symbol and ISIN of Ajooni Biotech?
Ajooni Biotech has the symbol AJOONI and ISIN - INE820Y01021.
What is the current price of Ajooni Biotech?
Ajooni Biotech is currently trading at INR 4.18.
What are the year high and year low of Ajooni Biotech?
Ajooni Biotech has a year high of INR 5.94 and a year low of INR 3.08.
What is the market capitalization of Ajooni Biotech?
Ajooni Biotech has a market capitalization of INR 72.69 crore.
What is the P/E ratio of Ajooni Biotech?
Ajooni Biotech has a P/E ratio of 13.85.
What is the dividend yield of Ajooni Biotech?
Ajooni Biotech has a dividend yield of 0.00%.
How is the financial performance of Ajooni Biotech based on revenue, net income, and EPS?
Ajooni Biotech has revenue of INR 182.38 crore, net income of INR 4.32 crore, and EPS of INR 0.28.
What is the book value of Ajooni Biotech?
Ajooni Biotech has a book value of INR 5.27.
What is the debt-to-equity ratio of Ajooni Biotech?
Ajooni Biotech has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Ajooni Biotech?
Ajooni Biotech has a price-to-book ratio of 0.79 and a price-to-sales ratio of 0.40.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.